Last reviewed · How we verify
Morphine hydrochloride, remifentanil hydrochloride — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Morphine hydrochloride, remifentanil hydrochloride (Morphine hydrochloride, remifentanil hydrochloride) — St Vincent's University Hospital, Ireland.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Morphine hydrochloride, remifentanil hydrochloride TARGET | Morphine hydrochloride, remifentanil hydrochloride | St Vincent's University Hospital, Ireland | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Morphine hydrochloride, remifentanil hydrochloride CI watch — RSS
- Morphine hydrochloride, remifentanil hydrochloride CI watch — Atom
- Morphine hydrochloride, remifentanil hydrochloride CI watch — JSON
- Morphine hydrochloride, remifentanil hydrochloride alone — RSS
Cite this brief
Drug Landscape (2026). Morphine hydrochloride, remifentanil hydrochloride — Competitive Intelligence Brief. https://druglandscape.com/ci/morphine-hydrochloride-remifentanil-hydrochloride. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab